C10 (HitGen/Kelun-Biotech)

N/A

Report date: 2024/09/20 14:48:07
NME

Base Information

Drug NameC10 (HitGen/Kelun-Biotech)
Drug Alias NameC10 (HitGen/Kelun-Biotech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidy-1-prolyl isomerase inhibitors
TargetsPeptidy-1-prolyl isomerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHitgen IncSichuan Kelun-Biotech Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Kelun-Biotech Biopharmaceutical Co LtdHitgen Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A